在乳腺癌和宫癌中调节亡的miRNAs
Elmira Aboutalebi Vand Beilankouhi1, Maral Salek Maghsoodi1, Maryam Zamani Sani2
1Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran.
Cell biochemistry and biophysics
|July 5, 2024
概括
这项研究探讨了microRNAs (miRNAs) 和它们在细胞灭亡中的作用,这是一个关键的细胞死亡过程,在乳腺癌 (BC) 和子宫癌 (CC) 中. 了解这些分子机制对于开发针对这些常见女性癌症的新疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 癌症,特别是乳腺癌 (BC) 和子宫癌 (CC),对全球健康和经济造成重大负担.
- 微RNAs (miRNAs) 是小型非编码RNAs,在转录后调节基因表达,具有作为瘤反应因子或瘤抑制剂的作用.
- miRNAs影响关键的细胞过程,包括细胞亡,这是编程细胞死亡的规范形式,对组织稳定至关重要.
研究的目的:
- 为了研究微RNAs (miRNAs) 和亡之间的复杂关系.
- 探索miRNAs和亡在乳腺癌 (BC) 和子宫癌 (CC) 发病过程中的特定作用.
主要方法:
- 关于miRNA和亡的现有文献的综述.
- 分析miRNA参与调节促亡和抗亡途径的情况.
- 专注于乳腺癌和子宫癌的影响.
主要成果:
- miRNAs是亡的关键调节者,通过亲亡和抗亡机制影响编程细胞死亡.
- 特定miRNAs的失调与乳腺癌和宫癌的发展和进展有关.
- 在这些恶性瘤中,miRNAs可以调节控制细胞存活和死亡的信号通路.
结论:
- 微RNA在控制亡中起着至关重要的作用,影响乳腺癌和宫癌的发展.
- 向miRNA介导的亡途径为管理BC和CC提供了一个有希望的治疗策略.
- 对miRNA-apoptosis相互作用的进一步研究对于推进癌症治疗至关重要.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


